![Russell McMahen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Russell McMahen
Directeur Technique/Scientifique/R&D chez AYTU BIOPHARMA, INC.
Postes actifs de Russell McMahen
Sociétés | Poste | Début | Fin |
---|---|---|---|
AYTU BIOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 01/01/2021 | - |
Historique de carrière de Russell McMahen
Anciens postes connus de Russell McMahen
Sociétés | Poste | Début | Fin |
---|---|---|---|
NEOS THERAPEUTICS, INC. | Directeur des opérations | - | - |
Directeur Technique/Scientifique/R&D | 30/07/2010 | 01/01/2021 | |
IVAX Pharmaceuticals, Inc.
![]() IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Corporate Officer/Principal | - | - |
Formation de Russell McMahen
Louisiana Tech University | Undergraduate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Undergraduate Degree | 1 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AYTU BIOPHARMA, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Neos Therapeutics, Inc.
![]() Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
IVAX Pharmaceuticals, Inc.
![]() IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IVAX Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products, which are sold to wholesalers, retail drug chains, retail pharmacies, hospital groups, nursing home providers and government agencies in the United States. The company was founded in 1987 by Philip Frost and Michael Jaris. It is headquartered in Miami, FL. | Health Technology |
- Bourse
- Insiders
- Russell McMahen
- Expérience